Pharmaceuticals

Shandong Shengli Bioengineering Co., Ltd is a joint venture built by China Animal Husbandry Industry Co., Ltd and Shandong Shengli Co., Ltd. We are national high-tech enterprise, and mainly producing animal-specific antibiotic API, veterinary preparations and feed additives, such as Tiamulin Fumarate, Enramycin, Bambermycin, Nosiheptide, and Monensin, etc. Shengli strictly follows the current GMP regulations in Europe and the United States, establishes a sound quality management system, and has passed ISO9001, ISO14001, ISO45001 certification, and the US FDA site audit with "0-483". Tiamulin Fumarate API is the first to obtain the EU COS Certificate in China, Enramycin is the first to obtain Production and Sale Certificate domestically. Based in China, with a global business strategy, the company has built a global marketing network.

Nantong Jinghua Pharmaceutical Co.,Ltd is a public pharmaceutical company in China that was established in 1957, owning about 302 staffs, located in No. 20, 3 Haibin Road, Yanhai Economic Development Zone, Rudong, Nantong Jiangsu, China. We are appointed as a high-new-technical enterprise by Jiangsu Scientific technological Bureau. As a comprehensive, advanced and innovative GMP company, we focus on manufacture, R&D and sales of APIs, pharmaceutical intermediates. Our company produce Phenobarbital, Primidone, Fluorouracil, Phenylbutazone, Flucytosine, Piroxicam, and Propylthiouracil etc., in which the first five products have CEP certificates.

Established in 1996, North China Pharmaceutical Group Aino Co., Ltd. is located in the Economic and Technical Development zone, Shijiazhuang, Hebei Province, P.R. China. During these years North China Pharmaceutical Group Aino Co., Ltd has been majoring in developing, manufacturing and selling green APIs. As Aino’s leading product, ABAMECTIN and IVERMECTIN are widely used as the most effective and broad-spectrum insecticides in the world. AINO produces strictly in accordance with GMP standards and become the first batch of China abamectin companies allowed to enter the United States and Europe market.

NCPC Huasheng is one of subsidiaries of NCPC. It was established in 1995, and production began in 1996. •More than 20 years dedicated in the manufacturing of APIs •Floor area: 85,000m2 •Personel: about 1,000peoples

NORTH CHINA PHARMACEUTICAL GROUP SEMISYNTECH CO., LTD is a wholly-owned subsidiary of NCPC, which is specialized in manufacturing and sales of penicillin series products including pharmaceutical intermediates and APIs. The company is located in economic & technical development zone of Liangcun, Shijiazhuang.

Jiangsu Quality Horizons Pharmtech Co., Ltd., (abbreviated as QH Holding) is specialized in R&D, manufacturing, sales and marketing of Anthelmintic products.  Currently QH Holding owns three manufacturing sites, i.e.  Changzhou Yabang-QH Pharmachem Co., Ltd.，which been successfully inspected by WHO, EDQM and US FDA,  Lianyungang City Yahui Pharmachem Co., Ltd. and Inner Mongolia Quality Horizons Pharmaceutical Co., Ltd..  The company focuses on Anthelmintic Products，also developed other high value new products，exporting to more than 100 countries. We also offer contract manufacturing services for international big pharmaceutical companies on advanced new drug intermediates and APIs, and maintain long term strategic cooperation relationship with them. We are committed to providing superior quality products, cost effective solutions and innovative technologies to enable customers long-term market success.